449 related articles for article (PubMed ID: 32223077)
1. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19.
Steardo L; Steardo L; Zorec R; Verkhratsky A
Acta Physiol (Oxf); 2020 Jul; 229(3):e13473. PubMed ID: 32223077
[No Abstract] [Full Text] [Related]
2. Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications.
Murray E; Tomaszewski M; Guzik TJ
Cardiovasc Res; 2020 Jun; 116(7):e87-e89. PubMed ID: 32301968
[No Abstract] [Full Text] [Related]
3. COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation.
Tan CS; Yeoh SF; Long CM
Ann Acad Med Singap; 2020 Jun; 49(6):398-400. PubMed ID: 32712639
[No Abstract] [Full Text] [Related]
4. Androgen-driven COVID-19 infection - is testosterone an enemy or a friend?
Grubić Kezele T
Horm Mol Biol Clin Investig; 2020 Jun; 41(2):. PubMed ID: 32598310
[No Abstract] [Full Text] [Related]
5. [ACE2 and coronavirus - a question of balance and dynamics?].
Lundström A; Sandén P
Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329
[TBL] [Abstract][Full Text] [Related]
6. Potentially modifiable factors to reduce severity of COVID-19 in type 2 diabetes.
Dhurandhar NV; Akheruzzaman M; Hegde V
Nutr Diabetes; 2020 Aug; 10(1):30. PubMed ID: 32788586
[No Abstract] [Full Text] [Related]
7. COVID-19 challenging cell biology.
Bullerdiek J
Protoplasma; 2020 May; 257(3):619-620. PubMed ID: 32333127
[No Abstract] [Full Text] [Related]
8. Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Parkinsonism: Is There Evidence for Concern?
Monje MHG; Martínez-Fernández R
Mov Disord; 2020 Oct; 35(10):1725. PubMed ID: 33068472
[No Abstract] [Full Text] [Related]
9. Very low reporting rate of connective tissue diseases among coronavirus disease 2019 (Covid-19) patients and the renin-angiotensin system - An overlooked association?
Giollo A; Cioffi G; Rossini M; Viapiana O; De Simone G
Eur J Intern Med; 2020 Oct; 80():106-107. PubMed ID: 32553588
[No Abstract] [Full Text] [Related]
10. COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.
Siniorakis E; Arvanitakis S; Nikolopoulos I; Elkouris M
mBio; 2020 May; 11(3):. PubMed ID: 32444383
[No Abstract] [Full Text] [Related]
11. Covid-19: the renin-angiotensin system imbalance hypothesis.
Lanza K; Perez LG; Costa LB; Cordeiro TM; Palmeira VA; Ribeiro VT; Simões E Silva AC
Clin Sci (Lond); 2020 Jun; 134(11):1259-1264. PubMed ID: 32507883
[TBL] [Abstract][Full Text] [Related]
12. Could angiotensin-converting enzyme 1
Dević Pavlić S; Nadalin S; Starčević Čizmarević N; Buretić-Tomljanović A; Radojčić Badovinac A; Ristić S
J Renin Angiotensin Aldosterone Syst; 2020; 21(3):1470320320957157. PubMed ID: 32928023
[No Abstract] [Full Text] [Related]
13. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
Delpino MV; Quarleri J
Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170
[No Abstract] [Full Text] [Related]
14. The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19.
Tsioufis C; Dimitriadis K; Tousoulis D
Hellenic J Cardiol; 2020; 61(1):31-33. PubMed ID: 32450334
[No Abstract] [Full Text] [Related]
15. Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.
Turgeon RD; Zieroth S; Bewick D; Chow CM; Clarke B; Cowan S; Fordyce CB; Fournier A; Gin K; Gupta A; Hardiman S; Jackson S; Lau B; Leong-Poi H; Mansour S; Marelli A; Quraishi AR; Roifman I; Ruel M; Sapp J; Singh G; Small G; Virani S; Wood DA; Krahn A
Can J Cardiol; 2020 Aug; 36(8):1180-1182. PubMed ID: 32502522
[No Abstract] [Full Text] [Related]
16. COVID-19 and the kidney.
Hassanein M; Radhakrishnan Y; Sedor J; Vachharajani T; Vachharajani VT; Augustine J; Demirjian S; Thomas G
Cleve Clin J Med; 2020 Oct; 87(10):619-631. PubMed ID: 33004323
[TBL] [Abstract][Full Text] [Related]
17. COVID-19: Thinking about further mental and neurological disorders.
Monteiro-Junior RS
Med Hypotheses; 2020 Oct; 143():109894. PubMed ID: 32492561
[No Abstract] [Full Text] [Related]
18. Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?
Deng JL; Jiang YQ; Guo YK; Li HL
Chin Med J (Engl); 2020 Nov; 133(22):2650-2652. PubMed ID: 32804730
[No Abstract] [Full Text] [Related]
19. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.
Theoharides TC
Biofactors; 2020 May; 46(3):306-308. PubMed ID: 32339387
[No Abstract] [Full Text] [Related]
20. Neurotropism of SARS-CoV 2: Mechanisms and manifestations.
Conde Cardona G; Quintana Pájaro LD; Quintero Marzola ID; Ramos Villegas Y; Moscote Salazar LR
J Neurol Sci; 2020 May; 412():116824. PubMed ID: 32299010
[No Abstract] [Full Text] [Related]
[Next] [New Search]
